Solid pharmaceutical rigid sheet peel strength testing is a critical quality control procedure that measures the interlayer adhesion of multilayer composite sheets used in blister packaging for tablets and capsules. By quantifying peel force in accordance with recognized standards such as YBB, GB/T, ASTM, and ISO methods, manufacturers can prevent delamination, protect barrier performance, and safeguard drug stability throughout the product shelf life. This article provides a comprehensive technical overview of sample types, testing items, instrumentation, procedures, and practical applications of peel strength testing for pharmaceutical rigid sheets.
Technical Overview
Solid pharmaceutical rigid sheets are multilayer composite structures—typically based on PVC, PVDC, polypropylene (PP), polyethylene (PE), polyamide (PA), or aluminum foil—widely used as the forming web of blister packs for solid dosage forms such as tablets, capsules, and pills. Because each layer contributes a specific function (formability, moisture barrier, oxygen barrier, or printability), the structural integrity of the laminate depends directly on the quality of the bond between adjacent layers.
Peel strength testing quantifies the resistance of these interlayer bonds to separation. If adhesion is insufficient, the laminate may delaminate during thermoforming, printing, transportation, or long-term storage, creating channels for moisture and oxygen ingress that degrade the active pharmaceutical ingredient. If adhesion is excessive or uneven, forming performance and processability may suffer. Peel strength measurement therefore serves as a key release criterion for pharmaceutical packaging material manufacturers and as an essential incoming inspection item for drug producers.
Testing is performed on an electronic tensile testing machine or dedicated peel strength tester equipped with precision grips, a suitable load cell, and high-frequency data acquisition. The specimen is pre-separated at one end, clamped in the grips, and peeled apart at a constant speed while the instrument records the peel force profile. The results are expressed as average peel force per unit width (N/15 mm or N/mm) and evaluated against the limits specified in the applicable registration standard or product specification.
Testing Samples
Peel strength testing applies to all laminated or coated rigid sheets intended for solid pharmaceutical packaging. Typical sample categories include:
PVC Rigid Sheets and Coated Variants
Uncoated PVC rigid sheets, PVC sheets coated with PVDC (polyvinylidene chloride), or PVC sheets with acrylic or ACLAR-based barrier layers. The coating-to-substrate bond is a primary delamination risk point and is routinely evaluated.
PVC/PE and PA/AL/PVC Laminated Sheets
Two-layer and multi-layer laminates used for high-barrier and thermoformable blisters, including polyamide/aluminum/PVC tropical blister structures. Each lamination interface can be assessed individually.
PP and Cold-Formable Aluminum Laminates
Polypropylene rigid sheets for high-temperature sterilization applications and cold-formable aluminum composite foils, where interlayer adhesion must survive deep drawing and creep forming operations.
Printed and Laminated Surface Structures
Sheets incorporating printing primers, ink layers, or outer lacquer coatings, for which adhesion between the printed layer and the base film may also be verified using peel methodology.
Testing Items
The scope of peel strength evaluation for solid pharmaceutical rigid sheets typically covers the following items:
- Interlayer peel strength between adjacent laminate layers (N/15 mm or N/mm)
- 180-degree peel strength for flexible-to-flexible bonded specimens
- T-peel resistance for symmetric laminates per ASTM D1876
- 90-degree peel strength for flexible-bonded-to-rigid specimens per ISO 8510-1
- Peel force uniformity and minimum/maximum peel values across the peel profile
- Failure mode classification (adhesive failure at the interface versus cohesive failure within a layer)
- Verification of conformity with registered technical specifications and pharmacopoeial material monographs
Testing Methods
Reference Standards
Testing is generally conducted in accordance with one or more of the following standards, depending on the material structure and market requirements:
- YBB standards for pharmaceutical packaging materials (national drug packaging material standards of China), including the peel strength determination method for composite sheets
- GB/T 8808 — Peel test method for flexible laminated plastic materials
- ASTM D1876 — Peel resistance of adhesives (T-peel test)
- ASTM D3330 — Peel adhesion of pressure-sensitive tape (applicable to adhesive-bonded layers)
- ASTM F88 — Seal strength of flexible barrier materials (for seal-related evaluations)
- ISO 8510-1 / ISO 8510-2 — 90-degree and 180-degree peel tests for adhesives
Specimen Preparation
Specimens are cut from representative sheet samples in both machine direction and transverse direction where applicable. Typical preparation parameters are:
- Specimen width: 15 mm (or 25.4 mm when following ASTM-based procedures)
- Specimen length: approximately 200 mm, ensuring sufficient peel travel
- Pre-peeling: one end of the specimen is carefully separated by hand or with a blade over a length of approximately 30 to 50 mm without damaging the layers
- Conditioning: at least 4 hours at 23 ± 2 °C and 50 ± 5% relative humidity prior to testing, consistent with GB/T 2918 or ISO 291 conditioning practice
- Number of specimens: no fewer than five (frequently ten) per direction, with outliers handled according to the governing standard
Test Procedure
The pre-separated ends of the specimen are clamped in the upper and lower grips of the testing machine so that the peel angle remains constant during separation. A common test sequence is:
- Set the crosshead speed, typically 300 ± 30 mm/min for YBB and GB/T based procedures (other speeds may apply under ASTM or ISO methods)
- Start the test and peel the specimen over an effective length of at least 100 mm, avoiding initial and terminal transition zones in the data evaluation
- Record the peel force–extension curve and determine the average peel force over the steady-state region
- Calculate peel strength as the average force divided by specimen width (N/15 mm or N/mm)
- Report the mean, maximum, and minimum values, the standard deviation, the failure mode, and the test conditions
Result Evaluation
Results are compared against the acceptance criteria established in the product registration standard, the pharmacopoeial monograph, or the agreed technical specification. A consistent peel profile with the failure mode occurring at the intended interface indicates a well-controlled lamination process. Erratic force traces, stick-slip behavior, or unexpectedly low values signal process deviations in coating weight, drying, lamination temperature, or adhesive formulation and should trigger corrective investigation.
Applications
Peel strength data for solid pharmaceutical rigid sheets are used throughout the packaging and pharmaceutical product life cycle:
- Quality control and batch release of rigid sheet production lines in pharmaceutical packaging plants
- Incoming material inspection and supplier qualification by drug manufacturers
- Research and development of new multilayer structures, adhesives, and coating systems
- Process validation and periodic requalification of lamination and coating equipment
- Regulatory submissions, including drug master file documentation and packaging component registration dossiers
- Stability studies evaluating the durability of interlayer adhesion under accelerated and long-term storage conditions
- Failure analysis of delamination complaints and root cause investigation in combination studies with heat seal strength and barrier testing
Accredited third-party laboratories also provide independent peel strength verification for export registration, dispute resolution, and comparative benchmarking of materials from different suppliers.
FAQ
What is peel strength in pharmaceutical rigid sheets?
Peel strength is the force required to separate two bonded layers of a laminate per unit width of the specimen, typically expressed in N/15 mm or N/mm. It reflects the quality of the interlayer bond and the reliability of the composite structure during forming, filling, and storage.
Which standards govern peel strength testing for pharmaceutical rigid sheets?
In China, the YBB drug packaging material standards and GB/T 8808 are commonly applied. Internationally, ASTM D1876, ASTM D3330, ASTM F88, and ISO 8510-1/-2 provide recognized peel test procedures. The choice of standard depends on the laminate structure and the target market.
What specimen dimensions and test speed are typically used?
A typical configuration uses specimens 15 mm wide and approximately 200 mm long, pre-peeled by 30 to 50 mm at one end, tested at a crosshead speed of 300 ± 30 mm/min. ASTM-based methods may use 25.4 mm wide strips and different speeds, so the governing standard should always be confirmed before testing.
How many specimens should be tested?
A minimum of five valid specimens per direction is standard practice, and ten specimens provide better statistical confidence. Results are reported as the arithmetic mean together with the standard deviation and observed failure mode.
What is the difference between peel strength and heat seal strength?
Peel strength measures the adhesion between layers within the laminate itself, whereas heat seal strength measures the force needed to separate two sealed webs, such as the rigid forming sheet and the lidding foil of a blister. Both properties are essential but evaluate different interfaces and use different specimen preparation methods.
What does a low or irregular peel result indicate?
Low or inconsistent peel values usually point to inadequate adhesive coating, insufficient lamination pressure or temperature, contamination between layers, or poor coating uniformity. Because delamination compromises barrier performance and may affect drug stability, out-of-specification results require prompt process investigation and corrective action.
